RBM22P5

Across TCGA pan-cancer cohorts, RBM22P5 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RBM22P5’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RBM22P5 RNA is repressed in tumor relative to normal tissue. In most cancer types RBM22P5 is over-expressed in tumor, although a few such as COAD and BRCA show the opposite, repressed pattern.

COAD, KIRC, and BRCA are the cancer types where RBM22P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM22P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−0.049	.009	6	view →
KIRC	Male	All	+0.013	.006	3	view →
BRCA	All	II,III,IV	−0.007	.043	2	view →
KICH	All	All	−0.013	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RBM22P5–COAD

Open the COAD breakdown →